Global Retinal Vein Occlusion Market Research Report 2023

Report ID: 1988068 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinal Vein Occlusion Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Branch Retinal Artery Occlusion
        1.2.3 Central Retinal Vein Occlusion
    1.3 Market by Application
        1.3.1 Global Retinal Vein Occlusion Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals and Clinics
        1.3.3 Research and Academics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Retinal Vein Occlusion Market Perspective (2017-2028)
    2.2 Retinal Vein Occlusion Growth Trends by Region
        2.2.1 Retinal Vein Occlusion Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Retinal Vein Occlusion Historic Market Size by Region (2017-2022)
        2.2.3 Retinal Vein Occlusion Forecasted Market Size by Region (2023-2028)
    2.3 Retinal Vein Occlusion Market Dynamics
        2.3.1 Retinal Vein Occlusion Industry Trends
        2.3.2 Retinal Vein Occlusion Market Drivers
        2.3.3 Retinal Vein Occlusion Market Challenges
        2.3.4 Retinal Vein Occlusion Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinal Vein Occlusion Players by Revenue
        3.1.1 Global Top Retinal Vein Occlusion Players by Revenue (2017-2022)
        3.1.2 Global Retinal Vein Occlusion Revenue Market Share by Players (2017-2022)
    3.2 Global Retinal Vein Occlusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinal Vein Occlusion Revenue
    3.4 Global Retinal Vein Occlusion Market Concentration Ratio
        3.4.1 Global Retinal Vein Occlusion Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinal Vein Occlusion Revenue in 2021
    3.5 Retinal Vein Occlusion Key Players Head office and Area Served
    3.6 Key Players Retinal Vein Occlusion Product Solution and Service
    3.7 Date of Enter into Retinal Vein Occlusion Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Vein Occlusion Breakdown Data by Type
    4.1 Global Retinal Vein Occlusion Historic Market Size by Type (2017-2022)
    4.2 Global Retinal Vein Occlusion Forecasted Market Size by Type (2023-2028)
5 Retinal Vein Occlusion Breakdown Data by Application
    5.1 Global Retinal Vein Occlusion Historic Market Size by Application (2017-2022)
    5.2 Global Retinal Vein Occlusion Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Retinal Vein Occlusion Market Size (2017-2028)
    6.2 North America Retinal Vein Occlusion Market Size by Country (2017-2022)
    6.3 North America Retinal Vein Occlusion Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Retinal Vein Occlusion Market Size (2017-2028)
    7.2 Europe Retinal Vein Occlusion Market Size by Country (2017-2022)
    7.3 Europe Retinal Vein Occlusion Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinal Vein Occlusion Market Size (2017-2028)
    8.2 Asia-Pacific Retinal Vein Occlusion Market Size by Country (2017-2022)
    8.3 Asia-Pacific Retinal Vein Occlusion Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Retinal Vein Occlusion Market Size (2017-2028)
    9.2 Latin America Retinal Vein Occlusion Market Size by Country (2017-2022)
    9.3 Latin America Retinal Vein Occlusion Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinal Vein Occlusion Market Size (2017-2028)
    10.2 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2017-2022)
    10.3 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Allergan
        11.1.1 Allergan Company Detail
        11.1.2 Allergan Business Overview
        11.1.3 Allergan Retinal Vein Occlusion Introduction
        11.1.4 Allergan Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.1.5 Allergan Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Detail
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Retinal Vein Occlusion Introduction
        11.2.4 Bayer Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.2.5 Bayer Recent Development
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Company Detail
        11.3.2 Bristol-Myers Squibb Business Overview
        11.3.3 Bristol-Myers Squibb Retinal Vein Occlusion Introduction
        11.3.4 Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Recent Development
    11.4 Regeneron Pharmaceuticals
        11.4.1 Regeneron Pharmaceuticals Company Detail
        11.4.2 Regeneron Pharmaceuticals Business Overview
        11.4.3 Regeneron Pharmaceuticals Retinal Vein Occlusion Introduction
        11.4.4 Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.4.5 Regeneron Pharmaceuticals Recent Development
    11.5 Ellex Medical Lasers
        11.5.1 Ellex Medical Lasers Company Detail
        11.5.2 Ellex Medical Lasers Business Overview
        11.5.3 Ellex Medical Lasers Retinal Vein Occlusion Introduction
        11.5.4 Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.5.5 Ellex Medical Lasers Recent Development
    11.6 GlaxoSmithKline Plc.
        11.6.1 GlaxoSmithKline Plc. Company Detail
        11.6.2 GlaxoSmithKline Plc. Business Overview
        11.6.3 GlaxoSmithKline Plc. Retinal Vein Occlusion Introduction
        11.6.4 GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.6.5 GlaxoSmithKline Plc. Recent Development
    11.7 IRIDEX Corporation
        11.7.1 IRIDEX Corporation Company Detail
        11.7.2 IRIDEX Corporation Business Overview
        11.7.3 IRIDEX Corporation Retinal Vein Occlusion Introduction
        11.7.4 IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.7.5 IRIDEX Corporation Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Retinal Vein Occlusion Introduction
        11.8.4 Novartis Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Quantel Medical Inc.
        11.9.1 Quantel Medical Inc. Company Detail
        11.9.2 Quantel Medical Inc. Business Overview
        11.9.3 Quantel Medical Inc. Retinal Vein Occlusion Introduction
        11.9.4 Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.9.5 Quantel Medical Inc. Recent Development
    11.10 Topcon Medical Systems, Inc.
        11.10.1 Topcon Medical Systems, Inc. Company Detail
        11.10.2 Topcon Medical Systems, Inc. Business Overview
        11.10.3 Topcon Medical Systems, Inc. Retinal Vein Occlusion Introduction
        11.10.4 Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.10.5 Topcon Medical Systems, Inc. Recent Development
    11.11 ZEISS
        11.11.1 ZEISS Company Detail
        11.11.2 ZEISS Business Overview
        11.11.3 ZEISS Retinal Vein Occlusion Introduction
        11.11.4 ZEISS Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.11.5 ZEISS Recent Development
    11.12 Lumenis
        11.12.1 Lumenis Company Detail
        11.12.2 Lumenis Business Overview
        11.12.3 Lumenis Retinal Vein Occlusion Introduction
        11.12.4 Lumenis Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.12.5 Lumenis Recent Development
    11.13 Sanofi Aventis
        11.13.1 Sanofi Aventis Company Detail
        11.13.2 Sanofi Aventis Business Overview
        11.13.3 Sanofi Aventis Retinal Vein Occlusion Introduction
        11.13.4 Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.13.5 Sanofi Aventis Recent Development
    11.14 Bausch Health
        11.14.1 Bausch Health Company Detail
        11.14.2 Bausch Health Business Overview
        11.14.3 Bausch Health Retinal Vein Occlusion Introduction
        11.14.4 Bausch Health Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.14.5 Bausch Health Recent Development
    11.15 Alimera Sciences
        11.15.1 Alimera Sciences Company Detail
        11.15.2 Alimera Sciences Business Overview
        11.15.3 Alimera Sciences Retinal Vein Occlusion Introduction
        11.15.4 Alimera Sciences Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.15.5 Alimera Sciences Recent Development
    11.16 Fovea Pharmaceuticals SA
        11.16.1 Fovea Pharmaceuticals SA Company Detail
        11.16.2 Fovea Pharmaceuticals SA Business Overview
        11.16.3 Fovea Pharmaceuticals SA Retinal Vein Occlusion Introduction
        11.16.4 Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.16.5 Fovea Pharmaceuticals SA Recent Development
    11.17 Icon Biosciences
        11.17.1 Icon Biosciences Company Detail
        11.17.2 Icon Biosciences Business Overview
        11.17.3 Icon Biosciences Retinal Vein Occlusion Introduction
        11.17.4 Icon Biosciences Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.17.5 Icon Biosciences Recent Development
    11.18 Suzuken Co.Ltd.
        11.18.1 Suzuken Co.Ltd. Company Detail
        11.18.2 Suzuken Co.Ltd. Business Overview
        11.18.3 Suzuken Co.Ltd. Retinal Vein Occlusion Introduction
        11.18.4 Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.18.5 Suzuken Co.Ltd. Recent Development
    11.19 Genentech, Inc.
        11.19.1 Genentech, Inc. Company Detail
        11.19.2 Genentech, Inc. Business Overview
        11.19.3 Genentech, Inc. Retinal Vein Occlusion Introduction
        11.19.4 Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.19.5 Genentech, Inc. Recent Development
    11.20 Ranbaxy Pharmaceuticals
        11.20.1 Ranbaxy Pharmaceuticals Company Detail
        11.20.2 Ranbaxy Pharmaceuticals Business Overview
        11.20.3 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Introduction
        11.20.4 Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.20.5 Ranbaxy Pharmaceuticals Recent Development
    11.21 Johnson & Johnson Services, Inc.
        11.21.1 Johnson & Johnson Services, Inc. Company Detail
        11.21.2 Johnson & Johnson Services, Inc. Business Overview
        11.21.3 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Introduction
        11.21.4 Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.21.5 Johnson & Johnson Services, Inc. Recent Development
    11.22 Teva Pharmaceutical, Pfizer Inc.
        11.22.1 Teva Pharmaceutical, Pfizer Inc. Company Detail
        11.22.2 Teva Pharmaceutical, Pfizer Inc. Business Overview
        11.22.3 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Introduction
        11.22.4 Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.22.5 Teva Pharmaceutical, Pfizer Inc. Recent Development
    11.23 Astrazeneca
        11.23.1 Astrazeneca Company Detail
        11.23.2 Astrazeneca Business Overview
        11.23.3 Astrazeneca Retinal Vein Occlusion Introduction
        11.23.4 Astrazeneca Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.23.5 Astrazeneca Recent Development
    11.24 Aerpio Therapeutics Inc.
        11.24.1 Aerpio Therapeutics Inc. Company Detail
        11.24.2 Aerpio Therapeutics Inc. Business Overview
        11.24.3 Aerpio Therapeutics Inc. Retinal Vein Occlusion Introduction
        11.24.4 Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.24.5 Aerpio Therapeutics Inc. Recent Development
    11.25 Annexin Pharmaceuticals AB
        11.25.1 Annexin Pharmaceuticals AB Company Detail
        11.25.2 Annexin Pharmaceuticals AB Business Overview
        11.25.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Introduction
        11.25.4 Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2017-2022)
        11.25.5 Annexin Pharmaceuticals AB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinal Vein Occlusion Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Branch Retinal Artery Occlusion
    Table 3. Key Players of Central Retinal Vein Occlusion
    Table 4. Global Retinal Vein Occlusion Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Retinal Vein Occlusion Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Retinal Vein Occlusion Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Retinal Vein Occlusion Market Share by Region (2017-2022)
    Table 8. Global Retinal Vein Occlusion Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Retinal Vein Occlusion Market Share by Region (2023-2028)
    Table 10. Retinal Vein Occlusion Market Trends
    Table 11. Retinal Vein Occlusion Market Drivers
    Table 12. Retinal Vein Occlusion Market Challenges
    Table 13. Retinal Vein Occlusion Market Restraints
    Table 14. Global Retinal Vein Occlusion Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Retinal Vein Occlusion Market Share by Players (2017-2022)
    Table 16. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Vein Occlusion as of 2021)
    Table 17. Ranking of Global Top Retinal Vein Occlusion Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Retinal Vein Occlusion Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Retinal Vein Occlusion Product Solution and Service
    Table 21. Date of Enter into Retinal Vein Occlusion Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Retinal Vein Occlusion Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Retinal Vein Occlusion Revenue Market Share by Type (2017-2022)
    Table 25. Global Retinal Vein Occlusion Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Retinal Vein Occlusion Revenue Market Share by Type (2023-2028)
    Table 27. Global Retinal Vein Occlusion Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Retinal Vein Occlusion Revenue Market Share by Application (2017-2022)
    Table 29. Global Retinal Vein Occlusion Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Retinal Vein Occlusion Revenue Market Share by Application (2023-2028)
    Table 31. North America Retinal Vein Occlusion Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Retinal Vein Occlusion Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Retinal Vein Occlusion Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Retinal Vein Occlusion Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Retinal Vein Occlusion Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Retinal Vein Occlusion Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Allergan Company Detail
    Table 42. Allergan Business Overview
    Table 43. Allergan Retinal Vein Occlusion Product
    Table 44. Allergan Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 45. Allergan Recent Development
    Table 46. Bayer Company Detail
    Table 47. Bayer Business Overview
    Table 48. Bayer Retinal Vein Occlusion Product
    Table 49. Bayer Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 50. Bayer Recent Development
    Table 51. Bristol-Myers Squibb Company Detail
    Table 52. Bristol-Myers Squibb Business Overview
    Table 53. Bristol-Myers Squibb Retinal Vein Occlusion Product
    Table 54. Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 55. Bristol-Myers Squibb Recent Development
    Table 56. Regeneron Pharmaceuticals Company Detail
    Table 57. Regeneron Pharmaceuticals Business Overview
    Table 58. Regeneron Pharmaceuticals Retinal Vein Occlusion Product
    Table 59. Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 60. Regeneron Pharmaceuticals Recent Development
    Table 61. Ellex Medical Lasers Company Detail
    Table 62. Ellex Medical Lasers Business Overview
    Table 63. Ellex Medical Lasers Retinal Vein Occlusion Product
    Table 64. Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 65. Ellex Medical Lasers Recent Development
    Table 66. GlaxoSmithKline Plc. Company Detail
    Table 67. GlaxoSmithKline Plc. Business Overview
    Table 68. GlaxoSmithKline Plc. Retinal Vein Occlusion Product
    Table 69. GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 70. GlaxoSmithKline Plc. Recent Development
    Table 71. IRIDEX Corporation Company Detail
    Table 72. IRIDEX Corporation Business Overview
    Table 73. IRIDEX Corporation Retinal Vein Occlusion Product
    Table 74. IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 75. IRIDEX Corporation Recent Development
    Table 76. Novartis Company Detail
    Table 77. Novartis Business Overview
    Table 78. Novartis Retinal Vein Occlusion Product
    Table 79. Novartis Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 80. Novartis Recent Development
    Table 81. Quantel Medical Inc. Company Detail
    Table 82. Quantel Medical Inc. Business Overview
    Table 83. Quantel Medical Inc. Retinal Vein Occlusion Product
    Table 84. Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 85. Quantel Medical Inc. Recent Development
    Table 86. Topcon Medical Systems, Inc. Company Detail
    Table 87. Topcon Medical Systems, Inc. Business Overview
    Table 88. Topcon Medical Systems, Inc. Retinal Vein Occlusion Product
    Table 89. Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 90. Topcon Medical Systems, Inc. Recent Development
    Table 91. ZEISS Company Detail
    Table 92. ZEISS Business Overview
    Table 93. ZEISS Retinal Vein OcclusionProduct
    Table 94. ZEISS Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 95. ZEISS Recent Development
    Table 96. Lumenis Company Detail
    Table 97. Lumenis Business Overview
    Table 98. Lumenis Retinal Vein OcclusionProduct
    Table 99. Lumenis Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 100. Lumenis Recent Development
    Table 101. Sanofi Aventis Company Detail
    Table 102. Sanofi Aventis Business Overview
    Table 103. Sanofi Aventis Retinal Vein OcclusionProduct
    Table 104. Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 105. Sanofi Aventis Recent Development
    Table 106. Bausch Health Company Detail
    Table 107. Bausch Health Business Overview
    Table 108. Bausch Health Retinal Vein OcclusionProduct
    Table 109. Bausch Health Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 110. Bausch Health Recent Development
    Table 111. Alimera Sciences Company Detail
    Table 112. Alimera Sciences Business Overview
    Table 113. Alimera Sciences Retinal Vein OcclusionProduct
    Table 114. Alimera Sciences Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 115. Alimera Sciences Recent Development
    Table 116. Fovea Pharmaceuticals SA Company Detail
    Table 117. Fovea Pharmaceuticals SA Business Overview
    Table 118. Fovea Pharmaceuticals SA Retinal Vein OcclusionProduct
    Table 119. Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 120. Fovea Pharmaceuticals SA Recent Development
    Table 121. Icon Biosciences Company Detail
    Table 122. Icon Biosciences Business Overview
    Table 123. Icon Biosciences Retinal Vein OcclusionProduct
    Table 124. Icon Biosciences Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 125. Icon Biosciences Recent Development
    Table 126. Suzuken Co.Ltd. Company Detail
    Table 127. Suzuken Co.Ltd. Business Overview
    Table 128. Suzuken Co.Ltd. Retinal Vein OcclusionProduct
    Table 129. Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 130. Suzuken Co.Ltd. Recent Development
    Table 131. Genentech, Inc. Company Detail
    Table 132. Genentech, Inc. Business Overview
    Table 133. Genentech, Inc. Retinal Vein OcclusionProduct
    Table 134. Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 135. Genentech, Inc. Recent Development
    Table 136. Ranbaxy Pharmaceuticals Company Detail
    Table 137. Ranbaxy Pharmaceuticals Business Overview
    Table 138. Ranbaxy Pharmaceuticals Retinal Vein OcclusionProduct
    Table 139. Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 140. Ranbaxy Pharmaceuticals Recent Development
    Table 141. Johnson & Johnson Services, Inc. Company Detail
    Table 142. Johnson & Johnson Services, Inc. Business Overview
    Table 143. Johnson & Johnson Services, Inc. Retinal Vein OcclusionProduct
    Table 144. Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 145. Johnson & Johnson Services, Inc. Recent Development
    Table 146. Teva Pharmaceutical, Pfizer Inc. Company Detail
    Table 147. Teva Pharmaceutical, Pfizer Inc. Business Overview
    Table 148. Teva Pharmaceutical, Pfizer Inc. Retinal Vein OcclusionProduct
    Table 149. Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 150. Teva Pharmaceutical, Pfizer Inc. Recent Development
    Table 151. Astrazeneca Company Detail
    Table 152. Astrazeneca Business Overview
    Table 153. Astrazeneca Retinal Vein OcclusionProduct
    Table 154. Astrazeneca Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 155. Astrazeneca Recent Development
    Table 156. Aerpio Therapeutics Inc. Company Detail
    Table 157. Aerpio Therapeutics Inc. Business Overview
    Table 158. Aerpio Therapeutics Inc. Retinal Vein OcclusionProduct
    Table 159. Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 160. Aerpio Therapeutics Inc. Recent Development
    Table 161. Annexin Pharmaceuticals AB Company Detail
    Table 162. Annexin Pharmaceuticals AB Business Overview
    Table 163. Annexin Pharmaceuticals AB Retinal Vein OcclusionProduct
    Table 164. Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2017-2022) & (US$ Million)
    Table 165. Annexin Pharmaceuticals AB Recent Development
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinal Vein Occlusion Market Share by Type: 2021 VS 2028
    Figure 2. Branch Retinal Artery Occlusion Features
    Figure 3. Central Retinal Vein Occlusion Features
    Figure 4. Global Retinal Vein Occlusion Market Share by Application in 2021 & 2028
    Figure 5. Hospitals and Clinics Case Studies
    Figure 6. Research and Academics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Retinal Vein Occlusion Report Years Considered
    Figure 9. Global Retinal Vein Occlusion Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Retinal Vein Occlusion Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Retinal Vein Occlusion Market Share by Region: 2021 VS 2028
    Figure 12. Global Retinal Vein Occlusion Market Share by Players in 2021
    Figure 13. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Vein Occlusion as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Retinal Vein Occlusion Revenue in 2021
    Figure 15. North America Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Retinal Vein Occlusion Market Share by Country (2017-2028)
    Figure 17. United States Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Retinal Vein Occlusion Market Share by Country (2017-2028)
    Figure 21. Germany Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Retinal Vein Occlusion Market Share by Region (2017-2028)
    Figure 29. China Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Retinal Vein Occlusion Market Share by Country (2017-2028)
    Figure 37. Mexico Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Retinal Vein Occlusion Market Share by Country (2017-2028)
    Figure 41. Turkey Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Retinal Vein Occlusion Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Allergan Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 44. Bayer Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 46. Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 47. Ellex Medical Lasers Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 48. GlaxoSmithKline Plc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 49. IRIDEX Corporation Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 51. Quantel Medical Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 52. Topcon Medical Systems, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 53. ZEISS Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 54. Lumenis Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 55. Sanofi Aventis Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 56. Bausch Health Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 57. Alimera Sciences Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 58. Fovea Pharmaceuticals SA Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 59. Icon Biosciences Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 60. Suzuken Co.Ltd. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 61. Genentech, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 62. Ranbaxy Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 63. Johnson & Johnson Services, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 64. Teva Pharmaceutical, Pfizer Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 65. Astrazeneca Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 66. Aerpio Therapeutics Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 67. Annexin Pharmaceuticals AB Revenue Growth Rate in Retinal Vein Occlusion Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan
Bayer
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Ellex Medical Lasers
GlaxoSmithKline Plc.
IRIDEX Corporation
Novartis
Quantel Medical Inc.
Topcon Medical Systems, Inc.
ZEISS
Lumenis
Sanofi Aventis
Bausch Health
Alimera Sciences
Fovea Pharmaceuticals SA
Icon Biosciences
Suzuken Co.Ltd.
Genentech, Inc.
Ranbaxy Pharmaceuticals
Johnson & Johnson Services, Inc.
Teva Pharmaceutical, Pfizer Inc.
Astrazeneca
Aerpio Therapeutics Inc.
Annexin Pharmaceuticals AB
Frequently Asked Questions
Retinal Vein Occlusion report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Retinal Vein Occlusion report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Retinal Vein Occlusion report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

RF Power Amplifier

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Rickets

Rickets market is segmented by players, region (country), by Type and by Application. Players, st ... Read More

Roasted Snack

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More